apixaban 5 MG Oral Tablet
- RxCUI
- 1364445
- RxNorm name
- apixaban 5 MG Oral Tablet
- Display name
- apixaban 5 MG Oral Tablet
- Full name
- apixaban 5 MG Oral Tablet
- Term type
- SCD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:12
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ELIQUIS | APIXABAN | Cardinal Health 107, LLC | a454cd24-0c6d-46e8-b1e4-197388606175 | 2026-04-24 | Boxed warning, Warnings, Adverse reactions | 1364445 |
| ELIQUIS | APIXABAN | REMEDYREPACK INC. | 7be1f4c1-bb2f-4ded-ae9a-515d2a22f93e | 2025-08-29 | Boxed warning, Warnings, Adverse reactions | 1364445 |
| Apixaban | APIXABAN | Macleods Pharmaceuticals Limited | 396912c0-9f68-47ed-ba3f-8d9ace755a48 | 2025-04-03 | Boxed warning, Warnings, Adverse reactions | 1364445 |
| ELIQUIS | APIXABAN | Aphena Pharma Solutions - Tennessee, LLC | 41a133ef-e461-48ad-8221-b735bdd0ec25 | 2025-01-30 | Boxed warning, Warnings, Adverse reactions | 1364445 |
| ELIQUIS | APIXABAN | A-S Medication Solutions | 33a9046a-41cc-46c1-becc-2ff4d7d71538 | 2024-11-25 | Boxed warning, Warnings, Adverse reactions | 1364445 |
| ELIQUIS | APIXABAN | Proficient Rx LP | 33752f5d-2ca7-45c0-8292-b54742219b97 | 2024-06-01 | Boxed warning, Warnings, Adverse reactions | 1364445 |
| Apixaban | APIXABAN | Amneal Pharmaceuticals of New York LLC | 19a60552-374d-4b8b-a8ce-ceae252ea5ba | 2024-05-23 | Boxed warning, Warnings, Adverse reactions | 1364445 |
| ELIQUIS | APIXABAN | A-S Medication Solutions | 2f47aa0e-0235-4220-85dd-dfcb8ad0d009 | 2023-05-09 | Boxed warning, Warnings, Adverse reactions | 1364445 |
| apixaban | APIXABAN | Indoco Remedies Limited | 095a08ac-cf0e-497e-a682-ddef38d6b29c | 2021-06-15 | Boxed warning, Warnings, Adverse reactions | 1364445 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| a454cd24-0c6d-46e8-b1e4-197388606175 | apixaban 5 MG Oral Tablet [PSN] · apixaban 5 MG Oral Tablet [SCD] | 2 | 38 | These highlights do not include all the information needed to use ELIQUIS safely and effectively. See full prescribing information for ELIQUIS. ELIQUIS ® (apixaban) tablets, for oral use ELIQUIS ® (apixaban) tablets for oral suspension ELIQUIS ® SPRINKLE (apixaban) for oral suspension Initial U.S. Approval: 2012 | 20260424 |
| e9481622-7cc6-418a-acb6-c5450daae9b0 | apixaban 5 MG Oral Tablet [PSN] · apixaban 5 MG Oral Tablet [SCD] | 2 | 30 | These highlights do not include all the information needed to use ELIQUIS safely and effectively. See full prescribing information for ELIQUIS. ELIQUIS ® (apixaban) tablets, for oral use ELIQUIS ® (apixaban) tablets for oral suspension ELIQUIS ® SPRINKLE (apixaban) for oral suspension Initial U.S. Approval: 2012 | 20250417 |
| 33a9046a-41cc-46c1-becc-2ff4d7d71538 | apixaban 5 MG Oral Tablet [PSN] · apixaban 5 MG Oral Tablet [SCD] | 2 | 23 | These highlights do not include all the information needed to use ELIQUIS safely and effectively. See full prescribing information for ELIQUIS. ELIQUIS ® (apixaban) tablets, for oral use Initial U.S. Approval: 2012 | 20241125 |
| 19a60552-374d-4b8b-a8ce-ceae252ea5ba | apixaban 5 MG Oral Tablet [PSN] · apixaban 5 MG Oral Tablet [SCD] | 2 | 16 | These highlights do not include all the information needed to use APIXABAN TABLETS safely and effectively. See full prescribing information for APIXABAN TABLETS. APIXABAN tablets, for oral use Initial U.S. Approval: 2012 | 20240523 |
| 8917e527-990a-17c0-e053-2a95a90a4631 | apixaban 5 MG Oral Tablet [PSN] · apixaban 5 MG Oral Tablet [SCD] | 2 | 9 | Eliquis 5mg | 20240802 |
| 095a08ac-cf0e-497e-a682-ddef38d6b29c | apixaban 5 MG Oral Tablet [PSN] · apixaban 5 MG Oral Tablet [SCD] | 2 | 7 | HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use APIXABAN TABLETS safely and effectively. See full prescribing information for APIXABAN TABLETS. APIXABAN tablets, for oral use Initial U.S. Approval: 2012 | 20210615 |
| 41a133ef-e461-48ad-8221-b735bdd0ec25 | apixaban 5 MG Oral Tablet [PSN] · apixaban 5 MG Oral Tablet [SCD] | 2 | 4 | These highlights do not include all the information needed to use ELIQUIS safely and effectively. See full prescribing information for ELIQUIS. ELIQUIS ® (apixaban) tablets, for oral use Initial U.S. Approval: 2012 | 20250130 |
| 2f47aa0e-0235-4220-85dd-dfcb8ad0d009 | apixaban 5 MG Oral Tablet [PSN] · apixaban 5 MG Oral Tablet [SCD] | 2 | 3 | These highlights do not include all the information needed to use ELIQUIS safely and effectively. See full prescribing information for ELIQUIS. ELIQUIS ® (apixaban) tablets, for oral use Initial U.S. Approval: 2012 | 20230509 |
| 33752f5d-2ca7-45c0-8292-b54742219b97 | apixaban 5 MG Oral Tablet [PSN] · apixaban 5 MG Oral Tablet [SCD] | 2 | 2 | These highlights do not include all the information needed to use ELIQUIS safely and effectively. See full prescribing information for ELIQUIS. ELIQUIS ® (apixaban) tablets, for oral use Initial U.S. Approval: 2012 | 20240601 |
| 7be1f4c1-bb2f-4ded-ae9a-515d2a22f93e | apixaban 5 MG Oral Tablet [PSN] · apixaban 5 MG Oral Tablet [SCD] | 2 | 1 | These highlights do not include all the information needed to use ELIQUIS safely and effectively. See full prescribing information for ELIQUIS. ELIQUIS ® (apixaban) tablets, for oral use ELIQUIS ® (apixaban) tablets for oral suspension ELIQUIS ® SPRINKLE (apixaban) for oral suspension Initial U.S. Approval: 2012 | 20250829 |
| 396912c0-9f68-47ed-ba3f-8d9ace755a48 | apixaban 5 MG Oral Tablet [PSN] · apixaban 5 MG Oral Tablet [SCD] | 2 | 1 | These highlights do not include all the information needed to use APIXABAN TABLETS safely and effectively. See full prescribing information for APIXABAN TABLETS. APIXABAN tablets, for oral use Initial U.S. Approval: 2012 | 20250403 |